Linked Life Data

8083706

Source:http://linkedlifedata.com/resource/pubmed/id/8083706

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
1994-10-10
pubmed:abstractText
To evaluate the efficacy and safety of gemcitabine, a pyrimidine antimetabolite with activity against solid tumours.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1821-6
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1994
pubmed:articleTitle
Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study.
pubmed:affiliation
Manchester Lung Tumour Study Group, Wythenshawe Hospital, United Kingdom.
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't, Clinical Trial, Phase II